View Older Stories
-
Quanterix receives New York clinical laboratory permit
-
Canaccord Genuity Downgrades Quanterix Corp. (QTRX) to Hold
-
Quanterix (QTRX) Misses Q2 EPS by 34c ; Offers Guidance
-
Quanterix reaches cooperation agreement with Kent Lake Capital
-
Quanterix completes Akoya Biosciences acquisition for $20M cash plus stock
-
Quanterix (QTRX) Expands Reach with IVD and Large Reference Labs
-
Canaccord Genuity Reiterates Buy Rating on Quanterix Corp. (QTRX)
-
Quanterix (QTRX) Misses Q1 EPS by 10c, provides outlook
-
Quanterix (QTRX) and Akoya Biosciences (AKYA) Announce Amended Merger Agreement
-
Quanterix Corp. (QTRX) PT Lowered to $18 at Scotiabank
-
Tikvah Management Announces Intention to Vote AGAINST Quanterix’s (QTRX) Proposed Merger with Akoya Biosciences (AKYA)
-
Quanterix Corp. (QTRX) PT Lowered to $15 at Canaccord Genuity
-
Quanterix (QTRX) Misses Q4 EPS by 7c, provides guidance
-
Kent Lake Issues Letter to Quanterix (QTRX) Shareholders Regarding Opposition to the Company’s Proposed Merger with Akoya Biosciences (AKYA)
-
ROSEN, TOP RANKED GLOBAL COUNSEL, Encourages Quanterix Corporation Investors to Inquire About Securities Class Action Investigation - QTRX
-
ROSEN, A LEADING LAW FIRM, Encourages Quanterix Corporation Investors to Inquire About Securities Class Action Investigation - QTRX
-
ROSEN, TRUSTED INVESTOR COUNSEL, Encourages Quanterix Corporation Investors to Inquire About Securities Class Action Investigation - QTRX
-
ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Quanterix Corporation Investors to Inquire About Securities Class Action Investigation - QTRX
-
ROSEN, LEADING INVESTOR COUNSEL, Encourages Quanterix Corporation Investors to Inquire About Securities Class Action Investigation - QTRX
-
ROSEN, LEADING INVESTOR COUNSEL, Encourages Quanterix Corporation Investors to Inquire About Securities Class Action Investigation - QTRX
-
ROSEN, A TRUSTED AND LEADING LAW FIRM, Encourages Quanterix Corporation Investors to Inquire About Securities Class Action Investigation - QTRX
-
ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages Quanterix Corporation Investors to Inquire About Securities Class Action Investigation - QTRX
-
ROSEN, A LONGSTANDING LAW FIRM, Encourages Quanterix Corporation Investors to Inquire About Securities Class Action Investigation - QTRX
-
Canaccord Genuity Reiterates Buy Rating on Quanterix Corp. (QTRX)
-
ROSEN, TOP RANKED GLOBAL COUNSEL, Encourages Quanterix Corporation Investors to Inquire About Securities Class Action Investigation - QTRX
-
Quanterix (QTRX) Provides Update on Financial Performance
-
ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages Quanterix Corporation Investors to Inquire About Securities Class Action Investigation - QTRX
-
Quanterix (QTRX) to acqure Akoya Biosciences (AKYA)
-
ROSEN, NATIONAL TRIAL COUNSEL, Encourages Quanterix Corporation Investors to Inquire About Securities Class Action Investigation - QTRX
-
ROSEN, LEADING INVESTOR COUNSEL, Encourages Quanterix Corporation Investors to Inquire About Securities Class Action Investigation - QTRX
-
ROSEN, A LEADING AND LONGSTANDING FIRM, Encourages Quanterix Corporation Investors to Inquire About Securities Class Action Investigation - QTRX
-
ROSEN, A TRUSTED AND LEADING FIRM, Encourages Quanterix Corporation Investors to Inquire About Securities Class Action Investigation - QTRX
-
ROSEN, A GLOBALLY RECOGNIZED FIRM, Encourages Quanterix Corporation Investors to Inquire About Securities Class Action Investigation - QTRX
-
ROSEN, SKILLED INVESTOR COUNSEL, Encourages Quanterix Corporation Investors to Inquire About Securities Class Action Investigation - QTRX
-
ROSEN, RESPECTED INVESTOR RIGHTS COUNSEL, Encourages Quanterix Corporation Investors to Inquire About Securities Class Action Investigation - QTRX
-
ROSEN, A HIGHLY RECOGNIZED LAW FIRM, Encourages Quanterix Corporation Investors to Inquire About Securities Class Action Investigation - QTRX
-
ROSEN, RESPECTED INVESTOR COUNSEL, Encourages Quanterix Corporation Investors to Inquire About Securities Class Action Investigation - QTRX
-
ROSEN, TOP-RANKED INVESTOR COUNSEL, Encourages Quanterix Corporation Investors to Inquire About Securities Class Action Investigation - QTRX
-
ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Quanterix Corporation Investors to Inquire About Securities Class Action Investigation - QTRX
-
Quanterix (QTRX) Expands Capabilities with Strategic Acquisition of EMISSION
-
ROSEN, A GLOBALLY RESPECTED FIRM, Encourages Quanterix Corporation Investors to Inquire About Securities Class Action Investigation - QTRX
-
ROSEN, A LEADING INVESTOR RIGHTS LAW FIRM, Encourages Quanterix Corporation Investors to Inquire About Securities Class Action Investigation - QTRX
-
ROSEN, A LEADING LAW FIRM, Encourages Quanterix Corporation Investors to Inquire About Securities Class Action Investigation - QTRX
-
Quanterix Corp. (QTRX) PT Raised to $16 at TD Cowen
-
Quanterix (QTRX) Announces Commercialization of p-Tau 217 Test Kit
-
Quanterix (QTRX) Appoints Jeffrey Elliott to its Board
-
Quanterix Corp. (QTRX) PT Lowered to $15 at TD Cowen
-
Quanterix (QTRX) Presents Data Demonstrating Successful Multi-Marker Approach for Alzheimer’s Disease Detection that is More Effective than Standalone Plasma p-Tau 217
-
FOXA, GLBE, and SNOW added to Goldman's Americas Conviction list; 2 stocks removed
-
Goldman Sachs Adjusts Director's Cut of US Conviction List, Adds three names, Removes two

